Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients with Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma: Results from the Phase Ib KEYNOTE-012 Expansion Cohort
Journal of Clinical Oncology(2016)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined